贝瑞基因
(000710)
| 流通市值：33.15亿 | | | 总市值：34.93亿 |
| 流通股本：3.36亿 | | | 总股本：3.54亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 446,766,809.76 | 210,215,582.68 | 929,818,022.06 | 685,656,794.86 |
| 营业总成本 | 462,287,478.74 | 217,562,649.71 | 1,009,161,258.53 | 713,217,299.16 |
| 其他经营收益 | | | | |
| 营业利润 | -36,715,065.58 | -17,697,150.76 | -187,335,591.04 | -42,124,510.87 |
| 利润总额 | -36,176,584.02 | -17,582,816.16 | -189,556,166.06 | -43,285,852.64 |
| 净利润 | -43,116,696.55 | -19,069,431.37 | -196,294,138.02 | -50,421,996.34 |
| 每股收益 | | | | |
| 其他综合收益 | -7,132,745.91 | -4,233,147.77 | -5,649,446.76 | -10,490,907.17 |
| 综合收益总额 | -50,249,442.46 | -23,302,579.14 | -201,943,584.78 | -60,912,903.51 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,131,625,743.33 | 1,176,987,465.17 | 1,244,082,293.78 | 1,298,059,150.34 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,030,383,991.1 | 1,038,776,447.44 | 1,040,154,653.33 | 1,045,651,611.74 |
| 资产总计 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 | 2,343,710,762.08 |
| 流动负债: | | | | |
| 流动负债合计 | 533,267,195.78 | 559,547,889.76 | 635,994,474.78 | 521,041,842.54 |
| 非流动负债: | | | | |
| 非流动负债合计 | 174,899,331.56 | 145,425,952.44 | 144,149,822.78 | 173,392,383 |
| 负债合计 | 708,166,527.34 | 704,973,842.2 | 780,144,297.56 | 694,434,225.54 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,422,147,722.61 | 1,453,026,421.88 | 1,476,245,609.06 | 1,619,622,588.29 |
| 股东权益合计 | 1,453,843,207.09 | 1,510,790,070.41 | 1,504,092,649.55 | 1,649,276,536.54 |
| 负债和股东权益合计 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 | 2,343,710,762.08 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 443,730,903.67 | 206,722,702.38 | 1,095,475,926.23 | 767,296,029.7 |
| 经营活动现金流出小计 | 545,990,089.02 | 298,355,151.97 | 1,024,868,193.54 | 791,878,860.59 |
| 经营活动产生的现金流量净额 | -102,259,185.35 | -91,632,449.59 | 70,607,732.69 | -24,582,830.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,126,047.85 | 6,108,047.85 | 22,001,548.38 | 15,563,356.39 |
| 投资活动现金流出小计 | 31,943,775.89 | 19,749,812.17 | 87,746,350.17 | 69,821,812.69 |
| 投资活动产生的现金流量净额 | -25,817,728.04 | -13,641,764.32 | -65,744,801.79 | -54,258,456.3 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 155,048,868.9 | 145,048,868.9 | 184,448,975.65 | 174,868,975.65 |
| 筹资活动现金流出小计 | 172,647,346.38 | 115,468,486.12 | 172,392,535.09 | 151,731,490.53 |
| 筹资活动产生的现金流量净额 | -17,598,477.48 | 29,580,382.78 | 12,056,440.56 | 23,137,485.12 |
| 汇率变动对现金及现金等价物的影响 | -3,349,260.9 | -2,225,966.99 | -3,027,599.87 | -2,058,048.65 |
| 现金及现金等价物净增加额 | -149,024,651.77 | -77,919,798.12 | 13,891,771.59 | -57,761,850.72 |
| 期末现金及现金等价物余额 | 223,179,933.96 | 294,284,787.61 | 372,204,585.73 | 300,550,963.42 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -149,024,651.77 | - | 13,891,771.59 | - |